Mindray North America Expands BeneVision Distributed Monitoring System with BeneVision TM70 Wearable Patient Monitor PRWeb FacebookTwitterEmail MAHWAH, N.J. (PRWEB) March 01, 2021 Mindray North America, a global manufacturer of medical device solutions and technologies, today announced the release of the BeneVision TM70 Telemetry platform for the U.S. market. Taking full advantage of the licensed and FCC-protected Wireless Medical Telemetry Service (WMTS) spectrum, TM70 telemetry and the BeneVision Distributed Monitoring System (DMS) expand Mindray’s telemetry offering to the 1.4GHz bandwidth, further supporting continuous monitoring of ambulating patients and gap-free patient data to the Electronic Medical Record (EMR). “The BeneVision TM70 puts groundbreaking telemetry technology within reach, placing exceptional performance, reliability and scalability into the hands of clinicians of high-volume telemetry and step-down departments,” said Michael Mullen, Senior Marketing Manager - Service and Support, Mindray North America. “Our flexible BeneVision telemetry offerings are now expanded to include protected WMTS TM70 telemetry and the 5GHz WiFi TM80 telemetry solution. Such flexibility in platform solutions is consistent with Mindray’s commitment to apply meaningful innovation to drive impactful results such as improved patient outcomes and increased staff productivity,” continued Mike.